Vol 7, Supplement 5 (June 08, 2018): Translational Cancer Research

Editorial

When something goes wrong: B cell responses to hepatitis C virus

Vito Racanelli, Patrizia Leone

PDF Pages: S538-S540 Full Text (1647) COI Form Open Access

Radiotherapy in breast cancer through a value-based perspective

Sara Bartoncini, Stefania Martini, Umberto Ricardi, Pierfrancesco Franco

PDF Pages: S541-S544 Full Text (1522) COI Form Open Access

New light on the pancreatic cyst conundrum

Nathan A. Berger

PDF Pages: S545-S548 Full Text (4396) COI Form Open Access

Atezolizumab: state of art and future perspective in non-small cell lung cancer treatment

Silvia Vecchiarelli, Lorenza Landi, Federico Cappuzzo

PDF Pages: S549-S552 Full Text (2230) Open Access

Pembrolizumab and other immunotherapies in patients with extensive-stage small-cell lung cancer—are we entering a new era?

Jan Norum

PDF Pages: S553-S557 Full Text (2278) COI Form Open Access

FBXW7 circular RNA repress glioma tumorigenesis

Mariana Tomazini Pinto, Rui Manuel Reis

PDF Pages: S558-S561 Full Text (1503) COI Form Open Access

Neoadjuvant pertuzumab, T-DM1, weekly paclitaxel and possible anthracyclines in HER2 positive early breast cancer treatment— questions from the KRISTINE study

Jack P. Gleeson, Niamh M. Keegan, Patrick G. Morris

PDF Pages: S562-S567 Full Text (2236) COI Form Open Access

Non-small cell lung carcinoma: understanding cancer microenvironment to drive immunotherapy and patients’ selection

Angelo Castello, Egesta Lopci

PDF Pages: S568-S572 Full Text (1371) COI Form Open Access

Sparing chemotherapy with dual HER2 blockade in combination with endocrine therapy for advanced HER2 positive breast cancer

Gustavo Werutsky, Tomás Reinert, André Poisl Fay

PDF Pages: S573-S576 Full Text (1980) COI Form Open Access

Therapeutic potential of osimertinib in the treatment of lung cancer with HER2 aberrations

Guo-Qing Qian, Shi-Yong Sun

PDF Pages: S577-S579 Full Text (2202) COI Form Open Access

Anthracycline cardiotoxicity: new actors on the stage

Donato Cappetta, Konrad Urbanek, Francesco Rossi, Antonella De Angelis

PDF Pages: S580-S583 Full Text (2059) COI Form Open Access

Hypofractionated radiation therapy for early breast cancer and regional nodal irradiation—the jury is still out

Hilde Van Parijs, Nele Adriaenssens, Claire Verschraegen, Zineb Dahbi, Vincent Vinh-Hung, Guy Storme, Mark De Ridder, Nam P. Nguyen

PDF Pages: S584-S586 Full Text (1687) COI Form Open Access

Disrupting membrane lipids composition promotes tumorigenesis: the other dark side of cholesterol and the potential implication of gangliosides

Tony Lefebvre, Philippe Delannoy

PDF Pages: S587-S590 Full Text (1518) COI Form Open Access

Cancer immunotherapy: accelerating the immune response without releasing the brakes

Luis I. Terrazas, Felipe Vaca-Paniagua

PDF Pages: S591-S593 Full Text (1427) COI Form Open Access

CD73: a new biomarker in triple-negative breast cancer

Virginie Lafont, Henri-Alexandre Michaud, Nathalie Bonnefoy

PDF Pages: S594-S596 Full Text (4603) COI Form Open Access

Circular RNAs—a missing piece in pulmonary macrophage activation in silica-induced inflammation

Tomasz Powrózek, Teresa Małecka-Massalska

PDF Pages: S597-S599 Full Text (1304) COI Form Open Access

A novel approach to cancer therapy using melanin-containing patches

Cristina Martelli, Mario Clerici

PDF Pages: S600-S603 Full Text (2934) COI Form Open Access

The eligibility of primary tumor resection for de novo stage IV breast cancer patients

Tadahiko Shien

PDF Pages: S604-S607 Full Text (1735) COI Form Open Access

Gut microbes modulate host response to immune checkpoint inhibitor cancer immunotherapy

Kebin Liu, Chunwan Lu

PDF Pages: S608-S610 Full Text (3670) COI Form Open Access

LATITUDE and other coordinates in quality of life of prostate cancer patients

Maria Lucia Reale, Consuelo Buttigliero, Marcello Tucci, Rosario F. Di Stefano, Francesca Vignani, Massimo Di Maio

PDF Pages: S611-S615 Full Text (1862) COI Form Open Access

The microbiota impact: bacteria shaping immunity, disease and response to therapy

Marianna Nuti, Ilaria G. Zizzari, Andrea Botticelli, Lorenza Putignani, Paolo Marchetti

PDF Pages: S616-S619 Full Text (2116) COI Form Open Access

Hope for high risk chronic lymphocytic leukemia after ibrutinib failure

Ohad Benjamini

PDF Pages: S620-S623 Full Text (7937) COI Form Open Access

Perspective

Circular RNAs and competing endogenous RNA (ceRNA) networks

Apratim Mitra, Karl Pfeifer, Ki-Sun Park

PDF Pages: S624-S628 Full Text (5030) COI Form Open Access

Letter to the Editor

Response letter: “Novel lncRNA Erbb4-IR promotes diabetic kidney injury in db/db mice by targeting miR-29b”

Si F. Sun, Patrick M. K. Tang, Xiao R. Huang, Hui Y. Lan

PDF Pages: S629-S631 Full Text (1541) COI Form Open Access

Disclosure:

This supplement was published without any sponsorship or funding.